Viewing Study NCT03593083



Ignite Creation Date: 2024-05-06 @ 11:47 AM
Last Modification Date: 2024-10-26 @ 12:49 PM
Study NCT ID: NCT03593083
Status: COMPLETED
Last Update Posted: 2020-01-07
First Post: 2018-07-09

Brief Title: Acute Excposure of High Altitude on ECG and Non-invasive Blood Pressure
Sponsor: University of Zurich
Organization: University of Zurich

Study Overview

Official Title: Acute Exposure to Hypoxia in Precapillary Pulmonary Hypertension Physiological and Clinical Effects at Rest and During Exercise
Status: COMPLETED
Status Verified Date: 2020-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Randomized crossover trial in patients with Pulmonary Hypertension PAH CTEPH to assess the acute response of High Altitude Säntis 2500m above sea level on ECG repolarizations and non-invasive blood pressure measurements by Finapres NOVA Technology
Detailed Description: Low altitude baseline measurements will be performed in Zurich 460m asl including Echocardiography Right heart catheterization 6MWT pulmonary function test clinical assessment and blood gas Analysis

Randomly assigned to the order of testing the participants will be tested in Low Altitude Zurich 470m and at High Altitude 2500m

During the exposure High Alitude 2500m above sea level and low alitude Zurich up to 5 hours the participants ECG and non-invasively assessed blood pressure by Finapres at rest and under exercise will be collected

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None